Ring Therapeutics (Series C)
Funding Details
Awarder
Inbox
Date Award
March 9, 2023
Vertical
Gene Therapy and Nucleic Acid Medicine
Funding URL
View Funding Page
Funding Amount
$86,500,000
Company Info
Founding Year
2017
Founders
Flagship Pioneering
Market
Broad range of diseases
Location
Cambridge, MA, USA
Coinvestors
Alexandria Venture Investments, Altitude Life Science Ventures, CJ Investment, Flagship Pioneering, Invus, Kyowa Kirin Co., Partners Investment Co., T. Rowe Price Associates, UPMC Enterprises
Company Description

Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Gene Therapy and Nucleic Acid Medicine DealsView Funding Announcement